Literature DB >> 11983299

Apolipoprotein E4 and tau allele frequencies among Choctaw Indians.

J Neil Henderson1, Richard Crook, Julia Crook, John Hardy, Luisa Onstead, Linda Carson-Henderson, Pat Mayer, Bea Parker, Ronald Petersen, Birdie Williams.   

Abstract

Apolipoprotein genotyping and tau haplotyping were carried out on a series of cases with dementia and controls from the Choctaw Nation of Oklahoma. Both the Apolipoprotein E4 allele frequency and the tau H2 haplotype frequency were low in the Choctaw compared with Caucasians and there was the possibility that the association between dementia and the E4 allele was weaker than in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983299     DOI: 10.1016/s0304-3940(02)00150-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

1.  Predictors of performance on the MMSE and the DRS-2 among American Indian elders.

Authors:  Lori L Jervis; Alexandra Fickenscher; Janette Beals; C Munro Cullum; Douglas K Novins; Spero M Manson; David B Arciniegas
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

2.  Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings.

Authors:  Myron F Weiner; Roger N Rosenberg; Kyle B Womack; Doris A Svetlik; Carey Fuller; Julie Fields; Linda S Hynan
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Jul-Sep       Impact factor: 2.703

3.  Total Brain and Hippocampal Volumes and Cognition in Older American Indians: The Strong Heart Study.

Authors:  Brenna Cholerton; Adam Omidpanah; Tara M Madhyastha; Thomas J Grabowski; Astrid M Suchy-Dicey; Dean K Shibata; Lonnie A Nelson; Steven P Verney; Barbara V Howard; William T Longstreth; Thomas J Montine; Dedra Buchwald
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Apr-Jun       Impact factor: 2.703

4.  Remote Neuropsychological Assessment in Rural American Indians with and without Cognitive Impairment.

Authors:  Hannah E Wadsworth; Jeanine M Galusha-Glasscock; Kyle B Womack; Mary Quiceno; Myron F Weiner; Linda S Hynan; Jay Shore; C Munro Cullum
Journal:  Arch Clin Neuropsychol       Date:  2016-05-30       Impact factor: 2.813

5.  The relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians.

Authors:  Myron F Weiner; Linda S Hynan; Heidi Rossetti; Kyle B Womack; Roger N Rosenberg; Yun-Hua Gong; Bao-Xi Qu
Journal:  Am J Geriatr Psychiatry       Date:  2011-05       Impact factor: 4.105

6.  APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study.

Authors:  Astrid Suchy-Dicey; Barbara Howard; W T Longstreth; Eric M Reiman; Dedra Buchwald
Journal:  Alzheimers Dement       Date:  2022-02-10       Impact factor: 16.655

7.  Cultural construction of disease: a "supernormal" construct of dementia in an American Indian tribe.

Authors:  J Neil Henderson; L Carson Henderson
Journal:  J Cross Cult Gerontol       Date:  2002

8.  Brain MRI, apoliprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls.

Authors:  Myron F Weiner; Carlos Marquez de la Plata; B A Julie Fields; Kyle B Womack; Roger N Rosenberg; Yun-Hua Gong; Bao-Xi Qu; Ramon Diaz-Arrastia; Linda S Hynan
Journal:  Curr Alzheimer Res       Date:  2009-02       Impact factor: 3.498

9.  Dissecting the role of Amerindian genetic ancestry and the ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population.

Authors:  Maria Victoria Marca-Ysabel; Farid Rajabli; Mario Cornejo-Olivas; Patrice G Whitehead; Natalia K Hofmann; Maryenela Zaida Illanes Manrique; Diego Martin Veliz Otani; Ana Karina Milla Neyra; Sheila Castro Suarez; Maria Meza Vega; Larry D Adams; Pedro R Mena; Isasi Rosario; Michael L Cuccaro; Jeffery M Vance; Gary W Beecham; Nilton Custodio; Rosa Montesinos; Pilar E Mazzetti Soler; Margaret A Pericak-Vance
Journal:  Neurobiol Aging       Date:  2020-12-10       Impact factor: 4.673

10.  APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.

Authors:  Sigrid B Sando; Stacey Melquist; Ashley Cannon; Michael L Hutton; Olav Sletvold; Ingvild Saltvedt; Linda R White; Stian Lydersen; Jan O Aasly
Journal:  BMC Neurol       Date:  2008-04-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.